# To Assess Safety, Tolerability and Physiological Effects on Structure and Function of AXA4010 in Subjects With Sickle Cell Disease

> **NCT04134299** · NA · COMPLETED · sponsor: **Axcella Health, Inc** · enrollment: 9 (actual)

## Conditions studied

- To Assess the Safety and Tolerabiltiy of an Amino Acid Composition in Subjects With Sickle Cell Disease
- Anemia, Sickle Cell
- Sickle Cell Anemia
- Sickle Cell Disorders
- Sickle Cell Disease

## Interventions

- **DIETARY_SUPPLEMENT:** AXA4010

## Key facts

- **NCT ID:** NCT04134299
- **Lead sponsor:** Axcella Health, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-25
- **Primary completion:** 2021-01-11
- **Final completion:** 2021-01-11
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2021-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04134299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04134299, "To Assess Safety, Tolerability and Physiological Effects on Structure and Function of AXA4010 in Subjects With Sickle Cell Disease". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT04134299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*